J8705 HCPCS code: Topotecan, oral, 0.25 mg
J8705 is the HCPCS Level II code for topotecan, oral, 0.25 mg. In 2024 Medicare paid an average of $90.55 per service for J8705 across 13,627 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 22 per day on outpatient hospital claims. Medicare volume fell 42% from 2022 to 2024 (23,690 to 13,627 services). In 2024, 43 suppliers billed Medicare for J8705 (purchases), serving 62 beneficiaries; Nevada, Virginia, Massachusetts accounted for 59% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 2009-01-01 |
| Last action effective | 2024-01-01 |
Who bills J8705 (2024)
| Measure | Value |
|---|---|
| Suppliers billing rentals | — |
| Suppliers billing purchases | 43 |
| Referring clinicians | 72 |
| Medicare beneficiaries | 62 |
| States with claims | 6 |
| Share of services in top 3 states (Nevada, Virginia, Massachusetts) | 59% |
| Year | Suppliers | Beneficiaries |
|---|---|---|
| 2022 | 71 | 99 |
| 2023 | 49 | 62 |
| 2024 | 43 | 62 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J8705, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 23,690 | 99 | $103.08 | $81.41 |
| 2023 | 11,109 | 62 | $101.86 | $79.78 |
| 2024 | 13,627 | 62 | $115.52 | $90.55 |
States with the most J8705 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Virginia | 1,100 | $89.11 |
| Nevada | 1,100 | $91.57 |
| Massachusetts | 900 | $91.01 |
| Maine | 845 | $91.90 |
| Ohio | 835 | $85.63 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 22 | Prescribing Information |
What changed for J8705
- 2009-01-01: J8705 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J8705?
J8705 is the HCPCS Level II code for topotecan, oral, 0.25 mg. Short descriptor: "Topotecan oral".
How much does Medicare pay for J8705?
In 2024, the average Medicare payment was $90.55 per service (average allowed $115.52).
Does Medicare cover J8705?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J8705 can be billed per day?
22 on outpatient hospital claims (NCCI medically unlikely edits).
Related J87 codes
- J8700 — Temozolomide, oral, 5 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J8705
- Watch J8705 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J8705
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.